C13.2
Malignant neoplasm of posterior wall of hypopharynx
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant neoplasm of the posterior wall of the hypopharynx refers to a type of throat cancer that originates in the back part of the hypopharynx, which is the lower part of the throat situated behind the larynx (voice box). This condition is classified under ICD-10 code C13.2. Recognizing and understanding this type of cancer are important steps in seeking appropriate medical attention and treatment.
Causes & Symptoms
Clinical Causes: Tobacco use, including smoking cigarettes and cigars Heavy alcohol consumption Chronic irritation caused by gastric reflux Poor oral hygiene and long-term use of certain mouth appliances Exposure to industrial or environmental toxins Infections with certain viruses, such as human papillomavirus (HPV), although less common
Key Symptoms: Persistent sore throat or hoarseness Difficulty swallowing or a sensation of something stuck in the throat Unexplained weight loss Lump or mass in the neck or throat Chronic cough or cough with blood Ear pain or ringing in the ears Difficulty breathing or noisy breathing in advanced cases
Diagnostic & Treatment
Diagnosis Path: Detecting a malignancy in the posterior wall of the hypopharynx involves several steps: - Physical examination of the throat and neck. - Imaging tests such as CT scans, MRI, or PET scans to visualize the tumor and assess its spread. - Endoscopic examination using a flexible or rigid laryngoscope to directly observe the interior of the throat. - Biopsy of the suspicious tissue to confirm the presence of cancer cells. - Additional tests may include blood work and assessments for metastasis to other parts of the body.
Treatment Protocols: Management of a malignant neoplasm in this region typically involves a multidisciplinary approach, including: - Surgical removal of the tumor, which may involve partial or total removal of the affected part of the hypopharynx. - Chemotherapy to target cancer cells throughout the body. - Radiation therapy to eliminate remaining cancer cells and reduce the risk of recurrence. - Targeted therapies or immunotherapy may be considered depending on the specific cancer characteristics. - Supportive care, including nutritional support and speech therapy, to help with recovery and quality of life post-treatment.
Clinical Advice & FAQs
Billing Guidance
Is C13.2 a billable ICD-10 code?
Yes, C13.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C13.2?
Clinical documentation must specify the nature of Malignant neoplasm of posterior wall of hypopharynx and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
